BioXcel Therapeutics, Inc. (BTAI) NASDAQ

1.57

-0.055(-3.40%)

Updated at February 12 10:39AM

Currency In USD

Valuation

Market Cap15.16M
Enterprise Value88.25M
P/E Ratio-0.33
PEG Ratio-0.01
Price/Sales Ratio45.51
Price/Book Ratio-0.25
Enterprise/Revenue141.21
Enterprise/EBITDA-2.07

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-90.71
Operating Margin-66.98

Management Effectiveness

Return On Assets-1.52
Return On Equity0.72

Income Statement

Revenue2.27M
Revenue/Share0.05
Gross Profit123,000
EBITDA-44.16M
Net Income-59.6M
Diluted EPS-23.51

Balance Sheet

Total Cash37.32M
Total Cash/Share2.63
Total Debt109.29M
Total Debt/Equity-1.23
Current Ratio1.17
Book Value Per Share-6.26

Price History

52-Week Change-44.31
52-Week High8.08
52-Week Low1.17
Moving Average 50 Days1.81
Moving Average 200 Days2.27

Statistics

Average Volume553,736
Shares Outstanding21.87M
% Held by Institutions30.06

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:16
Last Split DateFebruary 10, 2025